The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson
D A
DA
Department of Urology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
D014408:Biomarkers, Tumor / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood; D018997:Chorionic Gonadotropin, beta Subunit, Human; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006119:Groin; D006801:Humans; D008197:Lymph Node Excision / Q000379:methods; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000453:epidemiology; D009367:Neoplasm Staging; D009373:Neoplasms, Germ Cell and Embryonal / Q000097:blood / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D009919:Orchiectomy; D010446:Peptide Fragments / Q000097:blood; D012187:Retroperitoneal Space; D015996:Survival Rate; D013736:Testicular Neoplasms / Q000097:blood / Q000188:drug therapy / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D000509:alpha-Fetoproteins / Q000032:analysis
D014408:Biomarkers, Tumor; D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human; D010446:Peptide Fragments; D000509:alpha-Fetoproteins